Dr. John Boockvar Of Lenox Hill Hospital Talks New Surgical Technique To Treat Glioblastoma
Release Date: 02/24/2021
The Media's Viral Lie about Ivermectin Overdoses & Horse Medicine: Dr. Kory Responds | Interview
trialsitenews's podcast
In the last few weeks, the mainstream media ran with stories about Ivermectin, most noticeably referring to it as "horse medicine" or "horse dewormer" while, for some reason, leaving out the fact that Ivermectin is a WHO essential medicine for HUMANS.
info_outline
Kelly McKee from Medidata talks transforming the patient clinical trial experience
trialsitenews's podcast
An interview with Kelly McKee from Medidata on transforming the patient clinical trial experience.
info_outline
CATalyst | Indian Bar Association Serve Legal Notice on WHO's chief scientist Dr. Soumya Swaminathan
trialsitenews's podcast
info_outline
Ralph Lorigo Talks NY Court Rulings Over Ivermectin Use In Covid-19 Treatment | Interview
trialsitenews's podcast
We sit down with Ralph Lorigo, of the Law Office of Ralph C. Lorigo to discuss NY court cases regarding Ivermectin and Covid-19.
info_outline
Ralph Lorigo Talks NY Court Rulings Over Ivermectin Use In Covid-19 Treatment | Interview
trialsitenews's podcast
We sit down with Ralph Lorigo, of the Law Office of Ralph C. Lorigo to discuss NY court cases regarding Ivermectin and Covid-19.
info_outline
Shabnam Palesa Mohamed, discusses state of Ivermectin in South Africa | Podcast
trialsitenews's podcast
Shabnam Palesa Mohamed: Activist. journalist, mediator (LLB). Founder of SAHARI and THJ CEO, discusses state of Ivermectin in South Africa. We discuss the twists and turns of the legality issues of the drug, to a campaign to bring awareness through-out the country and beyond.
info_outline
Dr. Kedar discusses Covid-19 impact on bringing research to rural communities
trialsitenews's podcast
We talk with Dr. Kedar about rural research initiatives and the impact Covid-19 has had in bringing advanced research to them. Dr. Kedar specializes in autoimmune diseases that effect the musculoskeletal system, such as rheumatism, arthritis, and other disorders of the joints, muscles and ligaments.
info_outline
Melanie Rice: Patient Suffering from MS discusses her experience with the disease
trialsitenews's podcast
Melanie Rice who is suffering from Multiple Sclerosis. She was diagnosed Sept 20 2019 at the Mayo Clinic in Jacksonville Florida. Since then she has uncovered an entire community, or more appropriately, a family of thousands of people struggling with this autoimmune disease. She has become an advocate for MS patients, and so we have brought her on to talk with us about her illness.
info_outline
Sam Searcy Talks Accelerating The Clinical Trials Process With Cloud-Based Service Providers
trialsitenews's podcast
We sit down with Sam Searcy to talk about his Company Clinistart, and innovative cloud-based service providers designed to accelerate clinical trial site activation and study start up. The goal: accelerate each step of the clinical trials process to accelerate the availability of medicines sooner for patients.
info_outline
Dr. John Boockvar Of Lenox Hill Hospital Talks New Surgical Technique To Treat Glioblastoma
trialsitenews's podcast
We sit down for an interview with Dr. John Boockvar, vice chair of neurosurgery at Lenox Hill Hospital, who started a first-in-human clinical research study involving a new surgical technique to treat glioblastoma multiforme (GBM) - the most aggressive form of brain cancer.
info_outlineWe sit down for an interview with Dr. John Boockvar, vice chair of neurosurgery at Lenox Hill Hospital, who started a first-in-human clinical research study involving a new surgical technique to treat glioblastoma multiforme (GBM) - the most aggressive form of brain cancer.
Dr. Boockvar was one of the neurosurgeons featured on the highly praised Netflix series, Lenox Hill. See link here:
https://www.netflix.com/title/80201728
About the Procedure:
After standard tumor resection, the patient's own scalp tissue is harvested, rotated and engrafted and used to line the resected tumor cavity. It is our hope that by doing tissue autograft, it will allow to bypass the blood brain barrier so chemotherapeutics and immune cells can better reach the tumor site, improving treatment for GBM patients.
The study entitled, "Tissue Autograft to Bypass the Blood Brain Barrier (BBB) in Human Glioblastoma Multiforme," is being led by John Boockvar, MD, the hospital's vice chair, neurosurgery and director of Lenox Hill's Brain Tumor Center. To be eligible for the study, participants must be 18 years of age or older and plan to undergo resection of known or suspected GBM.
Press release about the first patient for further background:
https://www.northwell.edu/news/lenox-hill-first-to-study-using-tissue-autograft-for-gbm-tumors-in-humans
Lenox Hill's neurosurgery department webpage:
https://lenoxhill.northwell.edu/neurosurgery
Social Media:
Instagram: lhh_neurosurgery
Twitter: @LenoxNeurosurg
Dr. Boockvar, background link:
https://www.northwell.edu/about/leadership/john-andrew-boockvar-md
Dr. Boockvar's research at the Feinstein Institutes for Medical Research:
https://feinstein.northwell.edu/institutes-researchers/our-researchers/john-boockvar-md